glp-1 anesthesia news A narrative review of glucagon-like peptide-1 receptor agonists prior to deep sedation or general Anesthetic Considerations for Patients Taking
Description
D., Stine W
2 1
In addition to impaired EEC signaling and gut peptide release, GF models have impaired ENS activation compared with conventionalized and specific-pathogen-free models 245,246
A meta-analysis of 42,920 participants from five randomized trials demonstrated that GLP-1 RAs are associated with a significant reduction in the risk of the composite cardiovascular disease in patients with diabetes and established ASCVD [53]
The difference between brand-name and compounded GLP-1 therapy is primarily economic and logistical, not clinical
Transplant Direct
